Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
NCT06637631

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

Led by Sanofi · Updated on 2026-04-21

260

Participants Needed

138

Research Sites

232 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of SAR441566 in adults with moderate to severe Crohn's Disease (CD). The primary objective of this study is to assess the efficacy of different doses of SAR441566 compared with placebo in participants with moderate to severe CD. This study will have an anticipated duration of up to 59 weeks which will include a screening period of 4 weeks (+7 calendar days if needed), followed by the Main Study (MS) treatment period, lasting 52 weeks, and a 2-week follow-up period after end of treatment for participants not enrolling in the Long Term Safety (LTS) study. The MS period includes a Double-Blind (DB) treatment period with 12 weeks of induction followed by 40 weeks of maintenance. Additionally, an Open Label (OL) period of up to 40 weeks will be offered to eligible participants. The combined duration of the DB maintenance and OL periods cannot exceed 40 weeks, depending on when participants switch.

CONDITIONS

Official Title

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female participants aged 18 to 75 years at the time of signing the informed consent form
  • Confirmed diagnosis of Crohn's Disease for at least 3 months before baseline
  • Confirmed moderate to severe Crohn's Disease based on Crohn's Disease Activity Index score, Simple Endoscopic Score, stool frequency, and abdominal pain score
  • History of prior exposure to standard treatments or advanced therapies with inadequate response, loss of response, or intolerance to at least one
  • On stable doses of standard treatments such as oral 5-ASA compounds, corticosteroids, thiopurines, or methotrexate before screening
  • Use of contraception by men and women according to local regulations; women must not be pregnant or breastfeeding
Not Eligible

You will not qualify if you...

  • Active ulcerative colitis, indeterminate colitis, or short bowel syndrome
  • Crohn's Disease limited to stomach, duodenum, jejunum, or perianal region without colon or ileum involvement
  • Known ongoing complications of Crohn's Disease such as fistula, abscess, symptomatic stricture, fulminant colitis, toxic megacolon, recent bowel resection within 3 months, or more than 3 bowel resections in history
  • Stool sample positive for infectious pathogens
  • Active tuberculosis or incompletely treated tuberculosis
  • Positive Hepatitis B surface antigen or core antibody, or positive Hepatitis C antibody at screening
  • Any active, chronic, or recurrent infections including herpes zoster or herpes simplex
  • Known HIV infection or positive HIV serology at screening
  • Active malignancies or lymphoproliferative diseases within 5 years before screening
  • History or presence of colonic mucosal dysplasia or adenomatous colonic polyps not removed during colonoscopy at screening
  • Infection requiring intravenous anti-infective treatment within 30 days or oral/intramuscular anti-infectives within 14 days before screening
  • Need for or receiving parenteral or exclusive enteral nutrition
  • Use of cyclosporine, tacrolimus, mycophenolate mofetil, or thalidomide within 30 days before screening
  • Fecal microbial transplantation within 30 days before screening
  • Previous exposure to natalizumab or oral carotegrast methyl
  • Intravenous corticosteroids within 14 days before or during screening
  • Therapeutic enema or suppository use within 14 days before or during screening, except for colonoscopy
  • Abnormal lab or other screening test results

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 138 locations

1

GI Alliance - Arizona Digestive Health - Sun City- Site Number : 8400020

Sun City, Arizona, United States, 85351

Actively Recruiting

2

Bristol Hospital- Site Number : 8400007

Bristol, Connecticut, United States, 06010

Actively Recruiting

3

Novum Research- Site Number : 8400021

Clermont, Florida, United States, 34711

Actively Recruiting

4

Homestead Associates in Research- Site Number : 8400012

Homestead, Florida, United States, 33033

Actively Recruiting

5

Clinical Research of Osceola- Site Number : 8400013

Kissimmee, Florida, United States, 34741

Actively Recruiting

6

Wellness Clinical Research - Miami Lakes - 8181 Northwest 154th Street- Site Number : 8400010

Miami Lakes, Florida, United States, 33016

Actively Recruiting

7

GCP Clinical Research- Site Number : 8400004

Tampa, Florida, United States, 33609

Actively Recruiting

8

GI Alliance - Glenview- Site Number : 8400015

Glenview, Illinois, United States, 60026

Actively Recruiting

9

Illinois Gastroenterology Group- Site Number : 8400011

Gurnee, Illinois, United States, 60031

Actively Recruiting

10

University of Michigan Health System - Ann Arbor- Site Number : 8400017

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

11

GI Alliance - Flowood- Site Number : 8400019

Flowood, Mississippi, United States, 39232

Actively Recruiting

12

Vector Clinical Trials- Site Number : 8400001

Las Vegas, Nevada, United States, 89128

Actively Recruiting

13

Queens Village Primary Medical Center- Site Number : 8400005

Queens Village, New York, United States, 11428

Actively Recruiting

14

Carolina Digestive Diseases and Endoscopy Center- Site Number : 8400014

Greenville, North Carolina, United States, 27834

Actively Recruiting

15

Frontier Clinical Research - Uniontown- Site Number : 8400009

Uniontown, Pennsylvania, United States, 15401

Actively Recruiting

16

Medical University Of South Carolina - MUSC Health Ashley River Tower - ART- Site Number : 8400016

Charleston, South Carolina, United States, 29401

Actively Recruiting

17

Gastro Health & Nutrition- Site Number : 8400003

Katy, Texas, United States, 77494

Actively Recruiting

18

Texas Digestive Disease Consultants - Southlake- Site Number : 8400002

Southlake, Texas, United States, 76092

Actively Recruiting

19

Washington Gastroenterology - Tacoma- Site Number : 8400008

Tacoma, Washington, United States, 98405

Actively Recruiting

20

Investigational Site Number : 0320002

San Miguel de Tucumán, Tucumán Province, Argentina, 4000

Actively Recruiting

21

Investigational Site Number : 0320003

Buenos Aires, Argentina, 1061

Actively Recruiting

22

Investigational Site Number : 0320005

Buenos Aires, Argentina, 1119

Actively Recruiting

23

Investigational Site Number : 0320001

Buenos Aires, Argentina, 1125

Actively Recruiting

24

Investigational Site Number : 0320004

Buenos Aires, Argentina, 1221

Actively Recruiting

25

Investigational Site Number : 0320006

Buenos Aires, Argentina, 1280

Actively Recruiting

26

Investigational Site Number : 0360002

Sydney, New South Wales, Australia, 2139

Actively Recruiting

27

Investigational Site Number : 0360001

South Brisbane, Queensland, Australia, 4101

Actively Recruiting

28

Investigational Site Number : 0360003

Parkville, Victoria, Australia, 3050

Actively Recruiting

29

Centro de Pesquisas da Clínica IBIS- Site Number : 0760001

Salvador, Estado de Bahia, Brazil, 41820-020

Actively Recruiting

30

Hospital Moinhos de Vento- Site Number : 0760006

Porto Alegre, Rio Grande do Sul, Brazil, 90035-902

Actively Recruiting

31

Hospital de Clinicas de Porto Alegre- Site Number : 0760007

Porto Alegre, Rio Grande do Sul, Brazil, 90035903

Actively Recruiting

32

Hospital Ernesto Dornelles- Site Number : 0760002

Porto Alegre, Rio Grande do Sul, Brazil, 90160-093

Actively Recruiting

33

Pesquisare Saude- Site Number : 0760004

Santo André, São Paulo, Brazil, 09080-110

Actively Recruiting

34

Investigational Site Number : 1000001

Gorna Oryahovitsa, Bulgaria, 5100

Actively Recruiting

35

Investigational Site Number : 1000004

Sofia, Bulgaria, 1431

Actively Recruiting

36

Investigational Site Number : 1000005

Sofia, Bulgaria, 1680

Actively Recruiting

37

Investigational Site Number : 1240001

Calgary, Alberta, Canada, T2N 4Z6

Actively Recruiting

38

Investigational Site Number : 1240003

Montreal, Quebec, Canada, H3H 1E8

Actively Recruiting

39

Investigational Site Number : 1240005

Québec, Quebec, Canada, G1N 4V3

Actively Recruiting

40

Investigational Site Number : 1520006

Concepción, Biobio, Chile, 4070038

Actively Recruiting

41

Investigational Site Number : 1520004

Talcahuano, Biobio, Chile, 2687000

Actively Recruiting

42

Investigational Site Number : 1520007

Temuco, La Araucanía, Chile, 4781156

Actively Recruiting

43

Investigational Site Number : 1520001

Santiago, Reg Metropolitana de Santiago, Chile, 8331143

Actively Recruiting

44

Investigational Site Number : 1520003

Santiago, Reg Metropolitana de Santiago, Chile, 8380456

Actively Recruiting

45

Investigational Site Number : 1520002

Viña del Mar, Valparaiso, Chile, 2540364

Actively Recruiting

46

Investigational Site Number : 1560008

Changzhou, China, 213003

Actively Recruiting

47

Investigational Site Number : 1560009

Chongqing, China, 400013

Actively Recruiting

48

Investigational Site Number : 1560012

Fuzhou, China, 350005

Actively Recruiting

49

Investigational Site Number : 1560001

Guangzhou, China, 510080

Actively Recruiting

50

Investigational Site Number : 1560002

Guangzhou, China, 510655

Actively Recruiting

51

Investigational Site Number : 1560004

Hangzhou, China, 310009

Actively Recruiting

52

Investigational Site Number : 1560003

Hangzhou, China, 310016

Actively Recruiting

53

Investigational Site Number : 1560007

Hefei, China, 230022

Actively Recruiting

54

Investigational Site Number : 1560011

Nanchang, China, 330006

Actively Recruiting

55

Investigational Site Number : 1560006

Shanghai, China, 200025

Actively Recruiting

56

Investigational Site Number : 1560005

Shanghai, China, 200127

Actively Recruiting

57

Investigational Site Number : 1560010

Suzhou, China, 215004

Actively Recruiting

58

Investigational Site Number : 1910004

Osijek, Croatia, 31000

Actively Recruiting

59

Investigational Site Number : 1910003

Zagreb, Croatia, 10000

Actively Recruiting

60

Investigational Site Number : 2030003

Brno, Czechia, 602 00

Actively Recruiting

61

Investigational Site Number : 2030002

Brno, Czechia, 636 00

Actively Recruiting

62

Investigational Site Number : 2030004

Hradec Králové, Czechia, 500 12

Actively Recruiting

63

Investigational Site Number : 2500005

Montpellier, France, 34295

Actively Recruiting

64

Investigational Site Number : 2500002

Nice, France, 06202

Actively Recruiting

65

Investigational Site Number : 2500004

Saint-Priest-en-Jarez, France, 42270

Actively Recruiting

66

Investigational Site Number : 2500003

Toulouse, France, 31059

Actively Recruiting

67

Investigational Site Number : 2500001

Vandœuvre-lès-Nancy, France, 54511

Actively Recruiting

68

Investigational Site Number : 2680006

Kutaisi, Georgia, 4600

Actively Recruiting

69

Investigational Site Number : 2680007

Tbilisi, Georgia, 0102

Actively Recruiting

70

Investigational Site Number : 2680001

Tbilisi, Georgia, 0144

Actively Recruiting

71

Investigational Site Number : 2680005

Tbilisi, Georgia, 0159

Actively Recruiting

72

Investigational Site Number : 2680002

Tbilisi, Georgia, 0160

Actively Recruiting

73

Investigational Site Number : 2680003

Tbilisi, Georgia, 0172

Actively Recruiting

74

Investigational Site Number : 2680004

Tbilisi, Georgia, 0180

Actively Recruiting

75

Investigational Site Number : 2760004

Berlin, Germany, 10318

Actively Recruiting

76

Investigational Site Number : 2760002

Berlin, Germany, 12203

Actively Recruiting

77

Investigational Site Number : 2760001

Fulda, Germany, 36043

Actively Recruiting

78

Investigational Site Number : 2760005

Halle, Germany, 06108

Actively Recruiting

79

Investigational Site Number : 2760006

Ludwigshafen, Germany, 67067

Actively Recruiting

80

Investigational Site Number : 3480003

Békéscsaba, Hungary, 5600

Actively Recruiting

81

Investigational Site Number : 3480008

Budapest, Hungary, 1085

Actively Recruiting

82

Investigational Site Number : 3480001

Gyöngyös, Hungary, 3200

Actively Recruiting

83

Investigational Site Number : 3480009

Gyöngyös, Hungary, 3200

Actively Recruiting

84

Investigational Site Number : 3480005

Szeged, Hungary, 6720

Actively Recruiting

85

Investigational Site Number : 3480006

Szekszárd, Hungary, 7100

Actively Recruiting

86

Investigational Site Number : 3480004

Tatabánya, Hungary, 2800

Actively Recruiting

87

Investigational Site Number : 3560007

Hyderabad, India, 500032

Actively Recruiting

88

Investigational Site Number : 3560003

Hyderabad, India, 500048

Actively Recruiting

89

Investigational Site Number : 3560009

Jaipur, India, 302001

Actively Recruiting

90

Investigational Site Number : 3560001

Jaipur, India, 302007

Actively Recruiting

91

Investigational Site Number : 3560005

Kolkata, India, 700020

Actively Recruiting

92

Investigational Site Number : 3560006

Pune, India, 412201

Actively Recruiting

93

Investigational Site Number : 3560002

Secunderabad, India, 500003

Actively Recruiting

94

Investigational Site Number : 3560013

Surat, India, 395002

Actively Recruiting

95

Investigational Site Number : 3560010

Surat, India, 395010

Actively Recruiting

96

Investigational Site Number : 3800009

Milan, Milano, Italy, 20097

Actively Recruiting

97

Investigational Site Number : 3800002

Milan, Milano, Italy, 20132

Actively Recruiting

98

Investigational Site Number : 3800004

Rozzano, Milano, Italy, 20089

Actively Recruiting

99

Investigational Site Number : 3800001

Padua, Padova, Italy, 35128

Actively Recruiting

100

Investigational Site Number : 3800008

Rome, Roma, Italy, 00128

Actively Recruiting

101

Investigational Site Number : 3800006

Rome, Roma, Italy, 00168

Actively Recruiting

102

Investigational Site Number : 3800005

Pisa, Italy, 56124

Actively Recruiting

103

Investigational Site Number : 3920004

Kashiwa, Chiba, Japan, 277-0871

Actively Recruiting

104

Investigational Site Number : 3920001

Sakura, Chiba, Japan, 285-0841

Actively Recruiting

105

Investigational Site Number : 3920005

Kitakyushu, Fukuoka, Japan, 802-0077

Actively Recruiting

106

Investigational Site Number : 3920006

Sapporo, Hokkaido, Japan, 004-0041

Actively Recruiting

107

Investigational Site Number : 3920010

Sapporo, Hokkaido, Japan, 064-0919

Actively Recruiting

108

Investigational Site Number : 3920007

Sapporo, Hokkaido, Japan, 065-0033

Actively Recruiting

109

Investigational Site Number : 3920008

Yahaba, Iwate, Japan, 028-3695

Actively Recruiting

110

Investigational Site Number : 3920019

Takamatsu, Kagawa-ken, Japan, 760-0017

Actively Recruiting

111

Investigational Site Number : 3920020

Nagaoka, Niigata, Japan, 940-2108

Actively Recruiting

112

Investigational Site Number : 3920003

Bunkyo, Tokyo, Japan, 113-8510

Actively Recruiting

113

Investigational Site Number : 3920013

Hiroshima, Japan, 734-0004

Actively Recruiting

114

Investigational Site Number : 3920018

Ōita, Japan, 870-0033

Actively Recruiting

115

Investigational Site Number : 3920011

Tokyo, Japan, 169-0073

Actively Recruiting

116

Investigational Site Number : 3920012

Wakayama, Japan, 640-8558

Actively Recruiting

117

Investigational Site Number : 4800001

Vacoas, Mauritius, 72218

Actively Recruiting

118

Investigational Site Number : 5280004

Breda, Netherlands, 4818 CK

Actively Recruiting

119

Investigational Site Number : 5280002

Nijmegen, Netherlands, 6525 GA

Actively Recruiting

120

Investigational Site Number : 5280001

Tilburg, Netherlands, 5022 GC

Actively Recruiting

121

Investigational Site Number : 5280003

Utrecht, Netherlands, 3584 CX

Actively Recruiting

122

Investigational Site Number : 6160005

Torun, Kuyavian-Pomeranian Voivodeship, Poland, 87-100

Actively Recruiting

123

Investigational Site Number : 6160006

Lublin, Lublin Voivodeship, Poland, 20-582

Actively Recruiting

124

Investigational Site Number : 6160004

Warsaw, Masovian Voivodeship, Poland, 00-332

Actively Recruiting

125

Investigational Site Number : 6160001

Warsaw, Masovian Voivodeship, Poland, 02-507

Actively Recruiting

126

Investigational Site Number : 6160002

Sopot, Pomeranian Voivodeship, Poland, 81-756

Actively Recruiting

127

Investigational Site Number : 6420004

Bucharest, Romania, 011461

Actively Recruiting

128

Investigational Site Number : 6420003

Constanța, Romania, 900673

Actively Recruiting

129

Investigational Site Number : 6420001

Timișoara, Romania, 300002

Actively Recruiting

130

Investigational Site Number : 4100002

Haeundae-Gu, Busan, South Korea, 48108

Actively Recruiting

131

Investigational Site Number : 4100001

Daegu, Daegu, South Korea, 41944

Actively Recruiting

132

Investigational Site Number : 4100003

Daejeon, Daejeon, South Korea, 34943

Actively Recruiting

133

Investigational Site Number : 7240002

Seville, Sevilla, Spain, 41009

Actively Recruiting

134

Investigational Site Number : 7240001

Madrid, Spain, 28046

Actively Recruiting

135

Investigational Site Number : 7920003

Istanbul, Turkey (Türkiye), 34899

Actively Recruiting

136

Investigational Site Number : 7920001

Mersin, Turkey (Türkiye), 33070

Actively Recruiting

137

Investigational Site Number : 7920006

Sanliurfa, Turkey (Türkiye), 63290

Actively Recruiting

138

Investigational Site Number : 7920002

Zonguldak, Turkey (Türkiye), 67000

Actively Recruiting

Loading map...

Research Team

T

Trial Transparency email recommended (Toll free for US & Canada)

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here